• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality.根据体表面积和体型调整的透析剂量与患者死亡率的性别特异性。
Clin J Am Soc Nephrol. 2012 Dec;7(12):1977-87. doi: 10.2215/CJN.00390112. Epub 2012 Sep 13.
2
Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.体表面积标准化的Kt/V:一种将透析剂量重新调整为体表面积的方法——对不同性别、不同体型患者的意义
Semin Dial. 2008 Sep-Oct;21(5):415-21. doi: 10.1111/j.1525-139X.2008.00482.x.
3
The association of standard Kt/V and surface area-normalized standard Kt/V with clinical outcomes in hemodialysis patients.标准 Kt/V 和表面积标准化标准 Kt/V 与血液透析患者临床结局的关系。
Hemodial Int. 2020 Oct;24(4):495-505. doi: 10.1111/hdi.12865. Epub 2020 Aug 18.
4
Dose of dialysis based on body surface area is markedly less in younger children than in older adolescents.基于体表面积的透析剂量在年幼儿童中明显低于较大青少年。
Clin J Am Soc Nephrol. 2010 May;5(5):821-7. doi: 10.2215/CJN.08171109. Epub 2010 Mar 18.
5
Can rescaling dose of dialysis to body surface area in the HEMO study explain the different responses to dose in women versus men?在 HEMO 研究中,根据体表面积调整透析剂量能否解释女性与男性对剂量反应的差异?
Clin J Am Soc Nephrol. 2010 Sep;5(9):1628-36. doi: 10.2215/CJN.02350310. Epub 2010 Jul 1.
6
Adequacy of quotidian hemodialysis.每日血液透析的充分性
Am J Kidney Dis. 2003 Jul;42(1 Suppl):42-8. doi: 10.1016/s0272-6386(03)00537-7.
7
Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients.血液透析患者中spKt/V最高水平时较高死亡率的危险因素。
Nephrol Dial Transplant. 2003 Jul;18(7):1339-44. doi: 10.1093/ndt/gfg162.
8
Predicting treatment dose for novel therapies using urea standard Kt/V.使用尿素标准化Kt/V预测新型疗法的治疗剂量。
Semin Dial. 2004 Mar-Apr;17(2):142-5. doi: 10.1111/j.0894-0959.2004.17212.x.
9
Dose of hemodialysis and survival: a marginal structural model analysis.血液透析剂量与生存率:边际结构模型分析
Am J Nephrol. 2014;39(5):383-91. doi: 10.1159/000362285. Epub 2014 Apr 26.
10
Effect of treatment frequency on haemodialysis dose: comparison of EKR and stdKt/V.治疗频率对血液透析剂量的影响:EKR与标准Kt/V的比较
Nephrol Dial Transplant. 2009 Sep;24(9):2797-803. doi: 10.1093/ndt/gfp177. Epub 2009 Apr 22.

引用本文的文献

1
The association between dose of hemodialysis and patients mortality in a prospective cohort study.前瞻性队列研究中血液透析剂量与患者死亡率的关系。
Sci Rep. 2022 Aug 12;12(1):13708. doi: 10.1038/s41598-022-17943-0.
2
Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment.韩国肾脏病学会 2021 年最佳血液透析治疗临床实践指南执行摘要。
Korean J Intern Med. 2022 Jul;37(4):701-718. doi: 10.3904/kjim.2021.543. Epub 2022 Jun 3.
3
Gender-specific differences in hemodialysis patients: a multicenter longitudinal study from Serbia.血液透析患者的性别特异性差异:来自塞尔维亚的一项多中心纵向研究。
Int Urol Nephrol. 2022 Dec;54(12):3233-3242. doi: 10.1007/s11255-022-03247-9. Epub 2022 Jul 2.
4
Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.韩国肾脏病学会2021年最佳血液透析治疗临床实践指南。
Kidney Res Clin Pract. 2021 Dec;40(Suppl 1):S1-S37. doi: 10.23876/j.krcp.21.600. Epub 2021 Dec 10.
5
Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.韩国肾脏病学会2021年最佳血液透析治疗临床实践指南执行摘要
Kidney Res Clin Pract. 2021 Dec;40(4):578-595. doi: 10.23876/j.krcp.21.700. Epub 2021 Dec 10.
6
: achievement, predictors and relationship to mortality in hemodialysis patients in the Gulf Cooperation Council countries: results from DOPPS (2012-18).海湾合作委员会国家血液透析患者的成就、预测因素及其与死亡率的关系:DOPPS(2012 - 18年)的结果
Clin Kidney J. 2020 Jan 22;14(3):820-830. doi: 10.1093/ckj/sfz195. eCollection 2021 Mar.
7
The association of standard Kt/V and surface area-normalized standard Kt/V with clinical outcomes in hemodialysis patients.标准 Kt/V 和表面积标准化标准 Kt/V 与血液透析患者临床结局的关系。
Hemodial Int. 2020 Oct;24(4):495-505. doi: 10.1111/hdi.12865. Epub 2020 Aug 18.
8
High-Resolution Three-Dimensional Photonic Scan-Derived Equations Improve Body Surface Area Prediction in Diverse Populations.高分辨率三维光子扫描衍生方程改善了不同人群的体表面积预测。
Obesity (Silver Spring). 2020 Apr;28(4):706-717. doi: 10.1002/oby.22743. Epub 2020 Feb 26.
9
Glomerular Hematuria: Cause or Consequence of Renal Inflammation?肾小球性血尿:是肾脏炎症的原因还是后果?
Int J Mol Sci. 2019 May 5;20(9):2205. doi: 10.3390/ijms20092205.
10
Residual renal function in incremental dialysis.递增式透析中的残余肾功能
Clin Kidney J. 2018 Dec;11(6):853-856. doi: 10.1093/ckj/sfy082. Epub 2018 Sep 11.

本文引用的文献

1
Extracellular fluid volume and glomerular filtration rate in 1878 healthy potential renal transplant donors: effects of age, gender, obesity and scaling.1878 例健康潜在肾移植供者的细胞外液量和肾小球滤过率:年龄、性别、肥胖和校正的影响。
Nephrol Dial Transplant. 2012 Apr;27(4):1429-37. doi: 10.1093/ndt/gfr479. Epub 2011 Nov 10.
2
Modeled urea distribution volume and mortality in the HEMO Study.模型化 HEMO 研究中的尿素分布容积和死亡率。
Clin J Am Soc Nephrol. 2011 May;6(5):1129-38. doi: 10.2215/CJN.06340710. Epub 2011 Apr 21.
3
Nocturnal hemodialysis: effects on solute clearance, quality of life, and patient survival.夜间血液透析:对溶质清除率、生活质量和患者生存率的影响。
Curr Opin Nephrol Hypertens. 2011 Mar;20(2):182-8. doi: 10.1097/MNH.0b013e3283437046.
4
Can rescaling dose of dialysis to body surface area in the HEMO study explain the different responses to dose in women versus men?在 HEMO 研究中,根据体表面积调整透析剂量能否解释女性与男性对剂量反应的差异?
Clin J Am Soc Nephrol. 2010 Sep;5(9):1628-36. doi: 10.2215/CJN.02350310. Epub 2010 Jul 1.
5
Dose of dialysis based on body surface area is markedly less in younger children than in older adolescents.基于体表面积的透析剂量在年幼儿童中明显低于较大青少年。
Clin J Am Soc Nephrol. 2010 May;5(5):821-7. doi: 10.2215/CJN.08171109. Epub 2010 Mar 18.
6
Association of hemodialysis treatment time and dose with mortality and the role of race and sex.血液透析治疗时间和剂量与死亡率的关系及种族和性别的作用。
Am J Kidney Dis. 2010 Jan;55(1):100-12. doi: 10.1053/j.ajkd.2009.08.007. Epub 2009 Oct 22.
7
Solute-solver: a web-based tool for modeling urea kinetics for a broad range of hemodialysis schedules in multiple patients.溶质求解器:一种基于网络的工具,用于对多名患者的多种血液透析方案的尿素动力学进行建模。
Am J Kidney Dis. 2009 Nov;54(5):798-809. doi: 10.1053/j.ajkd.2009.06.033.
8
Scaling of measured glomerular filtration rate in kidney donor candidates by anthropometric estimates of body surface area, body water, metabolic rate, or liver size.根据人体表面积、体水、代谢率或肝大小的人体测量估计值对肾脏供体候选者的实测肾小球滤过率进行标化。
Clin J Am Soc Nephrol. 2009 Oct;4(10):1575-83. doi: 10.2215/CJN.05581008. Epub 2009 Sep 17.
9
Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.体表面积标准化的Kt/V:一种将透析剂量重新调整为体表面积的方法——对不同性别、不同体型患者的意义
Semin Dial. 2008 Sep-Oct;21(5):415-21. doi: 10.1111/j.1525-139X.2008.00482.x.
10
Kt/V underestimates the hemodialysis dose in women and small men.Kt/V会低估女性和身材矮小男性的血液透析剂量。
Kidney Int. 2008 Aug;74(3):348-55. doi: 10.1038/ki.2008.185. Epub 2008 May 28.

根据体表面积和体型调整的透析剂量与患者死亡率的性别特异性。

Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality.

机构信息

Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.

出版信息

Clin J Am Soc Nephrol. 2012 Dec;7(12):1977-87. doi: 10.2215/CJN.00390112. Epub 2012 Sep 13.

DOI:10.2215/CJN.00390112
PMID:22977208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3513738/
Abstract

BACKGROUND AND OBJECTIVES

When hemodialysis dose is scaled to body water (V), women typically receive a greater dose than men, but their survival is not better given a similar dose. This study sought to determine whether rescaling dose to body surface area (SA) might reveal different associations among dose, sex, and mortality.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Single-pool Kt/V (spKt/V), equilibrated Kt/V, and standard Kt/V (stdKt/V) were computed using urea kinetic modeling on a prevalent cohort of 7229 patients undergoing thrice-weekly hemodialysis. Data were obtained from the Centers for Medicare & Medicaid Services 2008 ESRD Clinical Performance Measures Project. SA-normalized stdKt/V (SAN-stdKt/V) was calculated as stdKt/V × ratio of anthropometric volume to SA/17.5. Patients were grouped into sex-specific dose quintiles (reference: quintile 1 for men). Adjusted hazard ratios (HRs) for 1-year mortality were calculated using Cox regression.

RESULTS

spKt/V was higher in women (1.7 ± 0.3) than in men (1.5 ± 0.2; P<0.001), but SAN-stdKt/V was lower (women: 2.3 ± 0.2; men: 2.5 ± 0.3; P<0.001). For both sexes, mortality decreased as spKt/V increased, until spKt/V was 1.6-1.7 (quintile 4 for men: HR, 0.62; quintile 3 for women: HR, 0.64); no benefit was observed with higher spKt/V. HR for mortality decreased further at higher SAN-stdKt/V in both sexes (quintile 5 for men: HR, 0.69; quintile 5 for women: HR, 0.60).

CONCLUSIONS

SA-based dialysis dose results in dose-mortality relationships substantially different from those with volume-based dosing. SAN-stdKt/V analyses suggest women may be relatively underdosed when treated by V-based dosing. SAN-stdKt/V as a measure for dialysis dose may warrant further study.

摘要

背景和目的

当根据体水(V)调整血液透析剂量时,女性通常比男性接受更大的剂量,但在接受相似剂量的情况下,她们的存活率并没有提高。本研究旨在确定根据体表面积(SA)调整剂量是否会揭示剂量、性别和死亡率之间的不同关联。

设计、地点、参与者和测量:使用单池 Kt/V(spKt/V)、平衡 Kt/V 和标准 Kt/V(stdKt/V)通过对接受每周三次血液透析的 7229 例患者进行尿素动力学模型计算。数据来自医疗保险和医疗补助服务中心 2008 年 ESRD 临床绩效衡量项目。SA 标准化 stdKt/V(SAN-stdKt/V)的计算公式为 stdKt/V × 体容与 SA/17.5 的比值。患者按性别分为特定剂量五分位数(男性为五分位数 1)。使用 Cox 回归计算 1 年死亡率的调整后的危险比(HR)。

结果

女性的 spKt/V 高于男性(1.7 ± 0.3 比 1.5 ± 0.2;P<0.001),但 SAN-stdKt/V 较低(女性:2.3 ± 0.2;男性:2.5 ± 0.3;P<0.001)。对于两性,随着 spKt/V 的增加,死亡率降低,直到 spKt/V 为 1.6-1.7(男性五分位数 4:HR,0.62;女性五分位数 3:HR,0.64);更高的 spKt/V 没有带来益处。在两性中,SAN-stdKt/V 较高时,死亡率的 HR 进一步降低(男性五分位数 5:HR,0.69;女性五分位数 5:HR,0.60)。

结论

基于 SA 的透析剂量会导致与基于体积的剂量的剂量-死亡率关系大不相同。基于 SAN-stdKt/V 的分析表明,女性在接受基于 V 的剂量治疗时可能相对剂量不足。SAN-stdKt/V 作为透析剂量的衡量标准可能需要进一步研究。